Prostate cancer

J Urol. 1993 Dec;150(6):1865-6. doi: 10.1016/s0022-5347(17)35916-5.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adenocarcinoma* / mortality
  • Adenocarcinoma* / therapy
  • Aged
  • Biomarkers, Tumor / analysis
  • Combined Modality Therapy
  • Humans
  • Male
  • Middle Aged
  • Prostate-Specific Antigen / analysis
  • Prostatic Neoplasms* / mortality
  • Prostatic Neoplasms* / therapy
  • Survival Rate
  • Treatment Failure

Substances

  • Biomarkers, Tumor
  • Prostate-Specific Antigen